Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1983-10-03
1986-02-04
Jiles, Henry R.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514333, 514338, 514356, 546256, 546263, 546270, 546321, C07D21178, C07D40112, C07D40502, A61K 31455
Patent
active
045686815
ABSTRACT:
1,2,3,4-Tetrahydropyridines of the formula ##STR1## in which R.sup.1 is optionally substituted aryl or heterocyclic,
REFERENCES:
Chatterjea, J. N., "1,3-Dimethy1-2-Azafluorenore Meyer's Pyridine Synthesis", Chemical Abstracts 47:9972.
Bossert, F. et al., "4-Aryldihydropyridines", Angew. Chem. Int. Ed. Engl. 20, pp. 762-769 (1981).
Schramm, M. et al., "Novel Dihydropyridines with Positive Inotropic Action Through Activation of Ca.sup.2+ Channels", Nature, vol. 303, (Jun. 9, 1983), pp. 535-537.
Kazda Stanislav
Knorr Andreas
Wehinger Egbert
Bayer Aktiengesellschaft
Bjorkman Dale A.
Jiles Henry R.
LandOfFree
Antihypertensive tetrahydropyridine 3,5 dicarboxylic acid esters does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antihypertensive tetrahydropyridine 3,5 dicarboxylic acid esters, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antihypertensive tetrahydropyridine 3,5 dicarboxylic acid esters will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2341118